Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
He Yuan Biotech: Net Loss of 158 Million Yuan in 2025
He Yuan Biotechnology Announces Earnings Brief: In 2025, the company achieved a total revenue of 47.8614 million yuan, an increase of 89.80% year-over-year; net loss was 158 million yuan, compared to a loss of 151 million yuan in the same period last year. The new product Aofumin, approved for listing in July 2025, achieved sales breakthroughs, with increased market promotion and recognition of its clinical value, becoming a new growth point. Meanwhile, the company maintained high R&D investment, with steady progress in its research pipeline.